GSK Secures High Blood Pressure Drug in $950 Million Deal
GSK Plc agreed to buy 35Pharma Inc., a biotech with an early-stage high blood pressure drug, as the UK pharmaceutical…
GSK Plc agreed to buy 35Pharma Inc., a biotech with an early-stage high blood pressure drug, as the UK pharmaceutical…
GSK plc (NYSE:GSK) ranks among the best undervalued European stocks to buy now. On February 4, GSK plc (NYSE:GSK) announced…
By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) – GSK’s new CEO Luke Miels said on Wednesday that…
GSK Plc reported better-than-expected profit in the fourth quarter, buoyed by its HIV and asthma medicines. www.bloomberg.com #GSK #Profit #Lifted…
Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Pfizer to Exit ViiV Healthcare as GSK and…
Source: Bloomberg, 4:44 www.bloomberg.com #Stock #Movers #LVMH #Ferritti #GSK #Podcast
The growing scourge of food allergies drove U.K. heavyweight GSK to announce a $2.2 billion deal on Tuesday. www.marketwatch.com #GSK…
GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK…
GSK plc (NYSE:GSK) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. HSBC Sees Pharma Poised to…
Simon Jack,Business editorand Archie Mitchell Watch: GSK boss Dame Emma Walmsley lays out competitions facing the UK The US is…